<ul>
<li>2026 年大麻黑馬：税制改革如何重置股票估值</li>
</ul>
<p>根據 MarketBeat 的股票篩選工具，Tilray Brands、Canopy Growth 和 Flora Growth 是今天值得關注的三隻大麻股票。大麻股票是指那些主要業務涉及大麻行業的上市公司股票——例如種植者、加工商、零售商、與大麻素合作的製藥開發者或輔助服務提供商（設備、測試、分銷和技術）。投資者將其視為消費/健康或新興市場股票的一個子類別，雖然它們可能提供更高的增長潛力，但由於各地區法律的不同，也面臨着更高的法律、監管和市場波動風險。這些公司在過去幾天內的大麻股票交易量最高。</p>
<p>獲取 <strong>Tilray Brands</strong> 警報：</p>
<h2>Tilray Brands (TLRY)</h2>
<p>Tilray, Inc. 從事醫療大麻的研究、種植、加工和分銷。該公司在阿根廷、澳大利亞、加拿大、智利、克羅地亞、塞浦路斯、捷克共和國、德國、新西蘭和南非提供其產品。Tilray, Inc. 總部位於加拿大。</p>
<ul>
<li>MarketBeat 週迴顧 – 09/29 - 10/03</li>
</ul>
<p>閲讀我們關於 TLRY 的最新研究報告</p>
<h2>Canopy Growth (CGC)</h2>
<p>Canopy Growth Corporation 及其子公司從事大麻和大麻基產品的生產、分銷和銷售，主要用於娛樂和醫療目的，業務遍及美國、加拿大、德國及國際市場。它通過加拿大大麻、國際市場大麻和 Storz &amp; Bickel 三個部門運營。</p>
<ul>
<li>Tilray 的股價飆升是政治炒作的幻想嗎？</li>
</ul>
<p>閲讀我們關於 CGC 的最新研究報告</p>
<h2>Flora Growth (FLGC)</h2>
<p>Flora Growth Corp.及其子公司從事全球範圍內的醫療大麻及其衍生產品的種植、培育和開發。它通過三個部門運營：品牌之家、商業與批發以及製藥。該公司種植、加工並供應醫療級大麻花及大麻衍生的醫療和健康產品。</p>
<p>閲讀我們關於 FLGC 的最新研究報告</p>
<h2>瞭解更多</h2>
<ul>
<li>MarketBeat 2026 年 2 月值得擁有的五大股票</li>
<li>高通的分析師們放棄了——是時候勇敢了嗎？</li>
<li>3 只折扣零售股票值得關注，因為財報考驗估值</li>
<li>CRWD 股票：買入抄底還是小心估值？</li>
<li>3 只被忽視的股息股票適合 2026 年的動盪市場</li>
<li>SentinelOne 的拋售是警告信號還是機會？</li>
</ul>
<p><em>此即時新聞警報由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資$1,000 到 Tilray Brands 嗎？</h2>
<p>在考慮 Tilray Brands 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 Tilray Brands 並不在名單上。</p>
<p>雖然 Tilray Brands 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

FLGC

TLRY

<p>根據 MarketBeat 的報道，Tilray Brands、Canopy Growth 和 Flora Growth 被認為是值得研究的頂級大麻股票。這些公司涉及大麻行業的各個方面，包括種植和分銷。最近它們的交易量很高，顯示出投資者的興趣。儘管它們具有增長潛力，但由於監管和市場波動，大麻股票仍然存在風險。分析師目前對 Tilray 的評級為持有，建議投資者考慮其他頂級分析師推薦的股票</p>

<ul>
<li>The 2026 Cannabis Wildcard: How Tax Reform Could Reset Stock Valuations</li>
</ul>
<div class="lb-trans"><ul>
<li>2026 年大麻黑馬：税制改革如何重置股票估值</li>
</ul>
</div><p>Tilray Brands, Canopy Growth, and Flora Growth are the three Cannabis stocks to watch today, according to MarketBeat's stock screener tool. Cannabis stocks are shares of publicly traded companies whose primary business involves the cannabis industry—such as growers, processors, retailers, pharmaceutical developers working with cannabinoids, or ancillary service providers (equipment, testing, distribution, and technology). Investors treat them as a subcategory of consumer/health or emerging-market equities that can offer higher growth potential but also carry elevated legal, regulatory and market-volatility risks due to differing laws across jurisdictions. These companies had the highest dollar trading volume of any Cannabis stocks within the last several days.</p>
<div class="lb-trans"><p>根據 MarketBeat 的股票篩選工具，Tilray Brands、Canopy Growth 和 Flora Growth 是今天值得關注的三隻大麻股票。大麻股票是指那些主要業務涉及大麻行業的上市公司股票——例如種植者、加工商、零售商、與大麻素合作的製藥開發者或輔助服務提供商（設備、測試、分銷和技術）。投資者將其視為消費/健康或新興市場股票的一個子類別，雖然它們可能提供更高的增長潛力，但由於各地區法律的不同，也面臨着更高的法律、監管和市場波動風險。這些公司在過去幾天內的大麻股票交易量最高。</p>
</div><p>Get <strong>Tilray Brands</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Tilray Brands</strong> 警報：</p>
</div><h2>Tilray Brands (TLRY)</h2>
<div class="lb-trans"><h2>Tilray Brands (TLRY)</h2>
</div><p>Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.</p>
<div class="lb-trans"><p>Tilray, Inc. 從事醫療大麻的研究、種植、加工和分銷。該公司在阿根廷、澳大利亞、加拿大、智利、克羅地亞、塞浦路斯、捷克共和國、德國、新西蘭和南非提供其產品。Tilray, Inc. 總部位於加拿大。</p>
</div><ul>
<li>MarketBeat Week in Review – 09/29 - 10/03</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 週迴顧 – 09/29 - 10/03</li>
</ul>
</div><p>Read Our Latest Research Report on TLRY</p>
<div class="lb-trans"><p>閲讀我們關於 TLRY 的最新研究報告</p>
</div><h2>Canopy Growth (CGC)</h2>
<div class="lb-trans"><h2>Canopy Growth (CGC)</h2>
</div><p>Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz &amp; Bickel segments.</p>
<div class="lb-trans"><p>Canopy Growth Corporation 及其子公司從事大麻和大麻基產品的生產、分銷和銷售，主要用於娛樂和醫療目的，業務遍及美國、加拿大、德國及國際市場。它通過加拿大大麻、國際市場大麻和 Storz &amp; Bickel 三個部門運營。</p>
</div><ul>
<li>Is Tilray's Stock Price Surge a Pipe Dream of Political Hype?</li>
</ul>
<div class="lb-trans"><ul>
<li>Tilray 的股價飆升是政治炒作的幻想嗎？</li>
</ul>
</div><p>Read Our Latest Research Report on CGC</p>
<div class="lb-trans"><p>閲讀我們關於 CGC 的最新研究報告</p>
</div><h2>Flora Growth (FLGC)</h2>
<div class="lb-trans"><h2>Flora Growth (FLGC)</h2>
</div><p>Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products.</p>
<div class="lb-trans"><p>Flora Growth Corp.及其子公司從事全球範圍內的醫療大麻及其衍生產品的種植、培育和開發。它通過三個部門運營：品牌之家、商業與批發以及製藥。該公司種植、加工並供應醫療級大麻花及大麻衍生的醫療和健康產品。</p>
</div><p>Read Our Latest Research Report on FLGC</p>
<div class="lb-trans"><p>閲讀我們關於 FLGC 的最新研究報告</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>瞭解更多</h2>
</div><ul>
<li>MarketBeat's Top Five Stocks to Own in February 2026</li>
<li>Qualcomm’s Analysts Are Throwing in the Towel—Time to Be Brave?</li>
<li>3 Discount Retail Stocks to Watch as Earnings Put Valuations to the Test</li>
<li>CRWD Stock: Buy the Dip or Beware the Valuation?</li>
<li>3 Overlooked Dividend Stocks for Choppy Markets in 2026</li>
<li>Is SentinelOne's Sell-Off a Warning Sign or an Opportunity?</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 2026 年 2 月值得擁有的五大股票</li>
<li>高通的分析師們放棄了——是時候勇敢了嗎？</li>
<li>3 只折扣零售股票值得關注，因為財報考驗估值</li>
<li>CRWD 股票：買入抄底還是小心估值？</li>
<li>3 只被忽視的股息股票適合 2026 年的動盪市場</li>
<li>SentinelOne 的拋售是警告信號還是機會？</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞警報由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Tilray Brands Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資$1,000 到 Tilray Brands 嗎？</h2>
</div><p>Before you consider Tilray Brands, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Tilray Brands 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray Brands wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 Tilray Brands 並不在名單上。</p>
</div><p>While Tilray Brands currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Tilray Brands 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

2 月 18 日值得研究的頂級大麻股票